Description

Mauer et al developed a model for a personalized risk estimate for event-free survival for a patient with diffuse large B-cell lymphoma (DLBCL). These can help to identify a patient who may benefit from more aggressive management. The authors are from multiple institutions in North America and Europe.


 

Patient selection: diffuse large B-cell lymphoma

 

Outcome: event-free survival at 24 months(EFS24)

 

Parameters

(1) diameter in centimeters (bulky disease)

(2) ECOG performance status

(3) normalized serum LDH in IU/L

(4) stage

(5) absolute lymphocyte count (ALC)

(6) gender

(7) age in years

 

normalized LDH =

= (serum LDH) / (upper limit of the normal reference range)

 

points for absolute lymphocyte count =

= MAX(0,(-12.5 * ((absolute count)/1000) + 25)

 

Parameter

Findings

Points

diameter in cm

< 10 cm

0

 

>= 10 cm ("bulky")

15.2

ECOG performance

0 or 1

0

 

2, 3 or 4

19.6

stage

I

0

 

II

3.6

 

III

8.8

 

IV

23.7

gender

Female

0

 

Male

14.3

 

 

Normalized LDH

Points

<= 0.5

0

0.5 to 1.3

(30.87 * ((ratio)^2)) + (3.95 * (ratio)) - 11.23

1.31 to 5

(14.66 * (ratio)) + 25.59

> 5

100

 

 

Age

Points

< 70

0

70 to 85

(3.286 * (age)) - 230.3

> 85

49.1

 

total score =

= SUM(points for all 7 parameters)

 

Interpretation:

• minimum score 0

• maximum score: 250

• The higher the score the lower the chances of event-free survival at 24 months.

• The higher the IPI24 score and the IPI the less likely that the patient will be event-free at 24 months.

 

X =

= (0.01659 * (total score)) - 1.954

 

IPI24 score =

= 1 / (1 + EXP((-1) * X))

 


To read more or access our algorithms and calculators, please log in or register.